However, oral gavage of CSS dose-dependently suppressed the RS-induced anxiety- and depression-like behaviors: it increased RS-suppressed OT and suppressed RS-induced immobility (Fig. 1). The gene discussed is OXT; the disease is depressive symptom measurement.